To receive coverage for Xarelto, a person must be enrolled in a Medicare Part D prescription drug plan or a Medicare Advantage (Part C) plan that includes prescription drug coverage. This article ...
Trailing a big-selling rival from Pfizer and Bristol Myers Squibb, Bayer and Johnson & Johnson are looking for any opportunity to bolster their aging heart drug Xarelto. Now, just short of its 10th ...
A new oral suspension formulation of Xarelto has also been approved by the FDA. The Food and Drug Administration (FDA) has approved Xarelto ® (rivaroxaban) for 2 new pediatric indications: treatment ...
RARITAN, N.J., Dec. 20, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric ...
Medicare Part D and Medicare Advantage plans with prescription drug coverage may cover Xarelto if it appears on the plan’s formulary. A generic version of Xarelto (rivaroxaban) recently became ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results